Get the latest news and updates on FINTECH.TV Skye Bioscience’s Developing Treatment for Glaucoma Daily Download February 22, 2023 Share FacebookTwitterPinterestWhatsApp Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves. Related posts: Speculation Growing Over Uses for ChatGPT AI Sweater Aiming to Make Venture Capital More Accessible SEC Cracks Down on Kraken Exploring The Future Of The Metaverse Advertisement Latest articles Navigating the D-Gen Economy: Insights from Stocktwits CEO Howard Lindzon Market Movers: The Opening Bell February 20, 2026 Navigating the Liquidity Crunch: Insights from Key Advisors Wealth Management Market Movers: The Opening Bell February 20, 2026 Launching into the Future: Starfighters Space Role in the New U.S. Space Race Market Market Movers: The Opening Bell February 20, 2026 Market Volatility: Analyzing Economic Data and Geopolitical Tensions Market Movers: The Opening Bell February 20, 2026 Related articles Navigating the D-Gen Economy: Insights from Stocktwits CEO Howard Lindzon Market Movers: The Opening Bell February 20, 2026 Navigating the Liquidity Crunch: Insights from Key Advisors Wealth Management Market Movers: The Opening Bell February 20, 2026 Launching into the Future: Starfighters Space Role in the New U.S. Space Race Market Market Movers: The Opening Bell February 20, 2026